FDA Accepts sBLA and Grants Priority Review for BAVENCIO(R) (a...
DARMSTADT, Germany and NEW YORK, Feb. 11, 2019 /PRNewswire-AsiaNet/ -- Not intended for US, Canada and UK-based mediaMerck and Pfizer Inc. (NYSE: PFE) today announced that the US Food and Drug Administration (FDA) has accepted for Priority Review the supplemental Biologics License Application (sBLA) for ...
Authors: LATEST ASIANET NEWS RELEASES